After AstraZeneca (AZN) presented data at the ObesityWeek conference, Deutsche Bank said the company’s oral small molecule GLP1 drug ...
3don MSN
Researchers are weighing the effects of popular weight-loss medications like Ozempic on muscle mass. New work is "calling ...
Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...
Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular ...
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Dr. Nora Volkow, Director of the National Institutes of Health’s National Institute on Drug Abuse (NIDA), discusses her ...
Telehealth companies selling low-cost, compounded versions of popular weight-loss drugs, including Ozempic and Wegovy, are drawing increased interest from employers, Bloomberg reported Oct. 29.
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Grant ...
Metabolic and vascular disorders are risk factors for AD, and it has been suggested that medications to treat metabolic and ...
There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback